ATEA PHARMACEUTICALS INC (AVIR)
US04683R1068 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -174.01M | -135.96M | -115.90M | 121.20M | -10.90M | |||
| Depreciation Amortization | 428.00K | 416.00K | 300.00K | 0.00 | 0.00 | |||
| Change In Working Capital | 10.53M | 16.16M | -46.60M | -247.80M | 300.20M | |||
| Other non cash items | 36.14M | 33.98M | 41.30M | 39.60M | 7.50M | |||
| OPERATING CASH FLOW | -126.90M | -85.39M | -121.00M | -87.00M | 296.70M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | 0.00 | -1.90M | 0.00 | 0.00 | |||
| Other Investing Activity | 87.28M | 40.30M | -453.50M | N/A | N/A | |||
| INVESTING CASH FLOW | 87.28M | 40.30M | -455.40M | 0.00 | 0.00 | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 224.00K | 257.00K | 400.00K | 1.50M | 531.70M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 224.00K | 257.00K | 400.00K | 1.50M | 531.70M | |||
| CHANGE IN CASH | -39.39M | -44.84M | -576.00M | -85.50M | 828.40M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -126.90M | -85.39M | -121.00M | -87.00M | 296.70M | |||
| Capital Expenditure | N/A | 0.00 | -1.90M | 0.00 | 0.00 | |||
| FREE CASH FLOW | -126.90M | -85.39M | -122.90M | -87.00M | 296.70M | |||
All data in USD